Verve Therapeutics Statistics
Total Valuation
HMY has a market cap or net worth of $8.92 billion. The enterprise value is $8.54 billion.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Apr 11, 2025 |
Share Statistics
HMY has 622.18 million shares outstanding. The number of shares has increased by 1.73% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 622.18M |
| Shares Change (YoY) | +1.73% |
| Shares Change (QoQ) | -2.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 546.33M |
Valuation Ratios
The trailing PE ratio is 16.00 and the forward PE ratio is 8.62.
| PE Ratio | 16.00 |
| Forward PE | 8.62 |
| PS Ratio | 2.51 |
| Forward PS | n/a |
| PB Ratio | 3.66 |
| P/TBV Ratio | 3.68 |
| P/FCF Ratio | 17.00 |
| P/OCF Ratio | 8.94 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.47, with an EV/FCF ratio of 16.29.
| EV / Earnings | 15.33 |
| EV / Sales | 2.40 |
| EV / EBITDA | 7.47 |
| EV / EBIT | 9.41 |
| EV / FCF | 16.29 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.84 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.24 |
| Interest Coverage | 164.92 |
Financial Efficiency
Return on equity (ROE) is 24.78% and return on invested capital (ROIC) is 23.28%.
| Return on Equity (ROE) | 24.78% |
| Return on Assets (ROA) | 16.66% |
| Return on Invested Capital (ROIC) | 23.28% |
| Return on Capital Employed (ROCE) | 28.78% |
| Revenue Per Employee | $102,375 |
| Profits Per Employee | $16,055 |
| Employee Count | 34,715 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 12.45 |
Taxes
In the past 12 months, HMY has paid $208.98 million in taxes.
| Income Tax | 208.98M |
| Effective Tax Rate | 27.02% |
Stock Price Statistics
The stock price has increased by +46.30% in the last 52 weeks. The beta is 0.63, so HMY's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +46.30% |
| 50-Day Moving Average | 14.45 |
| 200-Day Moving Average | 12.33 |
| Relative Strength Index (RSI) | 49.95 |
| Average Volume (20 Days) | 3,251,834 |
Short Selling Information
| Short Interest | 8.94M |
| Short Previous Month | 14.54M |
| Short % of Shares Out | 1.91% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.33 |
Income Statement
In the last 12 months, HMY had revenue of $3.55 billion and earned $557.36 million in profits. Earnings per share was $0.88.
| Revenue | 3.55B |
| Gross Profit | 1.33B |
| Operating Income | 908.39M |
| Pretax Income | 34.56M |
| Net Income | 557.36M |
| EBITDA | 1.14B |
| EBIT | 908.39M |
| Earnings Per Share (EPS) | $0.88 |
Full Income StatementBalance Sheet
The company has $497.62 million in cash and $128.11 million in debt, giving a net cash position of $369.51 million or $0.59 per share.
| Cash & Cash Equivalents | 497.62M |
| Total Debt | 128.11M |
| Net Cash | 369.51M |
| Net Cash Per Share | $0.59 |
| Equity (Book Value) | 2.44B |
| Book Value Per Share | 3.90 |
| Working Capital | 413.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $997.79 million and capital expenditures -$494.44 million, giving a free cash flow of $524.49 million.
| Operating Cash Flow | 997.79M |
| Capital Expenditures | -494.44M |
| Free Cash Flow | 524.49M |
| FCF Per Share | $0.84 |
Full Cash Flow StatementMargins
Gross margin is 37.54%, with operating and profit margins of 25.56% and 15.68%.
| Gross Margin | 37.54% |
| Operating Margin | 25.56% |
| Pretax Margin | 21.76% |
| Profit Margin | 15.68% |
| EBITDA Margin | 32.18% |
| EBIT Margin | 25.56% |
| FCF Margin | 14.76% |
Dividends & Yields
This stock pays an annual dividend of $0.14, which amounts to a dividend yield of 0.98%.
| Dividend Per Share | $0.14 |
| Dividend Yield | 0.98% |
| Dividend Growth (YoY) | 47.69% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 15.72% |
| Buyback Yield | -1.73% |
| Shareholder Yield | -0.75% |
| Earnings Yield | 6.25% |
| FCF Yield | 5.88% |
Dividend DetailsAnalyst Forecast
The average price target for HMY is $12.20, which is -14.21% lower than the current price. The consensus rating is "Hold".
| Price Target | $12.20 |
| Price Target Difference | -14.21% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HMY has an Altman Z-Score of 4.73 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.73 |
| Piotroski F-Score | 8 |
